Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Interest Expenses (2023 - 2025)

Phibro Animal Health has reported Interest Expenses over the past 6 years, most recently at $12.5 million for Q4 2025.

  • Quarterly results put Interest Expenses at $12.5 million for Q4 2025, up 27.64% from a year ago — trailing twelve months through Dec 2025 was $43.7 million (up 44.79% YoY), and the annual figure for FY2025 was $37.2 million, up 61.77%.
  • Interest Expenses for Q4 2025 was $12.5 million at Phibro Animal Health, roughly flat from $12.5 million in the prior quarter.
  • Over the last five years, Interest Expenses for PAHC hit a ceiling of $12.5 million in Q3 2025 and a floor of $5.6 million in Q3 2023.
  • Median Interest Expenses over the past 3 years was $8.9 million (2024), compared with a mean of $8.5 million.
  • Peak annual rise in Interest Expenses hit 71.0% in 2025, while the deepest fall reached 27.64% in 2025.
  • Phibro Animal Health's Interest Expenses stood at $5.7 million in 2023, then skyrocketed by 70.85% to $9.8 million in 2024, then increased by 27.64% to $12.5 million in 2025.
  • The last three reported values for Interest Expenses were $12.5 million (Q4 2025), $12.5 million (Q3 2025), and $9.0 million (Q2 2025) per Business Quant data.